Available Grant Opportunities


Week of Aug 7th-11th, 2017

Check back often for weekly updates



New Faculty Orientation to Corporate & Foundation Relations
Date:           October 9th, 2017
Time:           3:00 PM – 5:00 PM
Location:    Danto Auditorium, U-M Cardiovascular Center
The Michigan Medicine Office of Corporate & Foundation Relations will present its “New Faculty Orientation to Corporate & Foundation Relations” on Monday, October 9th from 3:00 – 5:00 PM in Danto Auditorium in the Cardiovascular Center.  Any faculty member who has been at Michigan for less than three years is encouraged to attend.  The program will emphasize foundation grants, and will include a faculty panel describing the impact that foundation awards had on their early career and offering advice for prospective applicants to prestigious foundations supporting early career researchers (such as Howard Hughes, Doris Duke, Searle, Sloan, and others).
The CFR team will also offer an introduction to the Weekly Grant RFP Opportunities Report, and a brief tutorial on getting the most out of their non-federal RFP website and how faculty can easily sign up for grant auto-notifications by selecting targeted keywords.  Foundation funding grants have never been more important to early career faculty, and our team hopes to familiarize as many faculty across the medical enterprise with the opportunities that we can help them identify.  Faculty are asked to RSVP for this event with Maryann Fardig - mfardig@umich.edu – and we’ll look forward to seeing them on October 9th.
Program Schedule
3:00 – 3:05 Welcome & Introductions
3:05 – 4:30 Panel Discussion – Benefits of  Finding the Right Foundation for Early Career Support Confirmed Panelists (a few additions are also likely)
-          David Burke, Interim Chair – Human Genetics
-          Yukiko Yamashita, James Playfair McMurrich Collegiate Professor of the Life Sciences
-          Alan Boyle, Assistant Professor – Computational Medicine & Bioinformatics
4:30 – 5:00 Introduction to Michigan Medicine Corporate & Foundation Relations
-          Weekly Grant RFP Opportunities Report Overview
-          Maximizing the Value of the Grant RFP Website
-          New Key-word Auto-notification Capability


Melanoma Research Alliance – Please note that the funding opportunities of the Melanoma Research Alliance that were listed in the report of August 7-11, 2017 are being relisted in this report with updated URLs
·         Team Science Awards ($900,000 award, deadline October 6th, 2017)  https://www.curemelanoma.org/research/request-for-proposals/   Awards for team science are designed to foster a collaborative research process and promote transformational melanoma research advances with the potential for rapid clinical translation. Multidisciplinary teams of two or more established Principal Investigators and a Young Investigator with complementary expertise will receive up to $900,000 total over 3 years, to support projects with the potential to lead to transformative advances in prevention, detection, diagnosis, staging and/or treatment of melanoma. Letters of Intent (LOIs) are due on October 6, 2017.
·         Established Investigator Academic-Industry Partnership Awards ($300,000 award, deadline November 17th, 2017). https://www.curemelanoma.org/research/request-for-proposals/  These awards are designed to enhance translational research by extending academic capabilities to clinical investigations and to facilitate interactions between the academic and industrial research sectors. These awards will be co-funded by MRA and an industry partner whose involvement is essential to the project.  Investigators with an established record of scientific productivity will receive up to $100,000 per year for two to three years (up to $300,000 total) from MRA to conduct projects supported by preliminary data.  Industry Partners must contact Kristen Mueller, MRA Scientific Program Director, at kmueller@curemelanoma.org by November 10, 2017, to discuss the terms of the partnership agreement. All other questions regarding the award should be directed to Tasheema Prince, Scientific Program Manager, at tprince@curemelanoma.org.  Full proposals are due on November 17, 2017. No LOI is required under Established Investigator Academic-Industry Partnership Awards
·         Awards for Young Investigators ($225,000 award, deadline November 17th, 2017).  https://www.curemelanoma.org/research/request-for-proposals/ Young Investigator Awards aim to attract early career scientists with novel ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma research leaders. Awardees will be provided up to $75,000 per year for three years (up to $225,000 total) to accomplish innovative and creative, preclinical, translational, and/or early clinical research projects.
·         Award for Women in Scientific Research ($225,000 award, deadline November 17th, 2017).  https://www.curemelanoma.org/research/request-for-proposals/  MRA is proud to offer a Young Investigator Award with the goal of attracting and supporting early career female researchers who are conducting cutting-edge melanoma research. The awardee will receive up to $225,000 total over 3 years to support projects with the potential to lead to transformative advances in prevention, detection, diagnosis, staging or treatment of melanoma. For this Award, the PI must be a woman. Full proposals are due on November 17, 2017. No LOI is required under Young Investigator Awards.
American Heart Association – Collaborative Sciences Award ($750,000 award, deadline November 1st, 2017). http://professional.heart.org/professional/ResearchPrograms/UCM_460459_C... Statement of Purpose: To foster innovative, new collaborative approaches to research projects which propose novel pairings of investigators from at least two broadly disparate disciplines. The proposal must focus on the collaborative relationship, such that the scientific objectives could not be achieved without the efforts of at least two co-principal investigators and their respective disciplines. The combination and integration of studies may be inclusive of basic, clinical, population, behavioral, and/or translational research.
Projects that will include scientists from fields outside cardiovascular disease and stroke are highly encouraged.  Science Focus: Research broadly related to cardiovascular function and disease and stroke, or to related clinical, basic science, bioengineering or biotechnology, and public health problems, including multidisciplinary efforts. Disciplines: Proposals are encouraged from all basic disciplines as well as epidemiological, behavioral, community and clinical investigations that bear on cardiovascular and stroke problems. AHA awards are open to the array of academic and health professionals. This includes but is not limited to all academic disciplines (biology, chemistry, mathematics, technology, physics, etc.) and all health-related professions (physicians, nurses, advanced practice nurses, pharmacists, dentists, physical and occupational therapists, statisticians, nutritionists, behavioral scientists, engineers, etc.).

Foundation Fighting Blindness – Individual Investigator Research Grant Awards – Targeted Call for Proposals ($300,000 award, Letter of Intent deadline September 29th, 2017).  http://www.blindness.org/apply-for-funding  Individual Investigator Research Grant Awards are designed to concentrate research in areas that will have the greatest potential to move towards treatments and cures for the inherited orphan retinal degenerative diseases and dry age-related macular degeneration (dAMD).  N.B.:  FFB does not support research for neovascular AMD or diabetic retinopathy.  The Foundation has identified Research Priority Areas (RPA) that align with its mission and this targeted open call for application is to address specific gaps identified in current retinal disease research.  While applications addressing the areas of particular interest below will be given priority consideration, the FFB will also consider proposals for highly novel research that do not fit easily within these goals.  The LOI for such proposals must clearly explain why the research is likely to lead to prevention, treatments or cures for the orphan inherited retinal degenerative diseases. Individual research awards are available in the following Research Priority Areas: Novel Medical Therapies (NMT);  Gene Therapy (GT); Cell and Molecular Mechanisms of Retinal Disease (CMM); Genetics (GE); Clinical-Structure and Function (CL); and, Regenerative Medicine (RM). Award: The award will be approximately $100,000 per year up to three years.  If you are interested in being considered for an award, please send a Letter of Intent (LOI) and short Curriculum Vitae (NIH Biosketch is acceptable) to FFB by September 29, 2017.

DeGregorio Family Foundation for Gastric and Esophageal Cancer ($250,000 award, deadline November 7th, 2017).  http://www.degregorio.org/wp/7th-annual-degregorio-foundation-award/  The DeGregorio Family Foundation for Gastric and Esophageal Cancer (www.DeGregorio.org) is pleased to announce our 8th annual funding opportunity for gastroesophageal malignancies.  The Foundation seeks to promote and facilitate collaborative research on the pathogenesis, early diagnosis, and treatment of upper gastrointestinal malignancies.  We support high quality, innovative, and transformative translational and bench research to improve the understanding of the biology of these diseases, identification of potential novel therapeutic targets, or in the development and evaluation of novel biomarkers for early diagnosis and treatment.  Pre-clinical research, basic mechanistic studies, genomic/epigenomic studies, as well as epidemiologic studies may also be supported.
Up to $250,000 over two years will be awarded.
Esther A. & Joseph Klingenstein Fund & the Simons Foundation – Awards in the Neurosciences ($225,000 award, deadline February 15th, 2018). http://www.klingfund.org/index.php  The Esther A. & Joseph Klingenstein Fund and the Simons Foundation announce the opening of its 2018 competition for research fellowships in the neurosciences. Aimed at advancing cutting-edge investigations, the awards are presented to highly promising, early career scientists. At this critical juncture in young investigators' careers, when funding can be a challenge, the fellowship awards promote higher-risk, and potentially higher-reward, projects.


The Klingenstein-Simons Fellowship Awards in the Neurosciences supports, in the early stages of their careers, young investigators engaged in basic or clinical research that may lead to a better understanding of neurological and psychiatric disorders. The Klingenstein Fund and the Simons Foundation recognize that to accomplish this goal it is necessary to encourage a variety of new approaches. Several areas within the neurosciences are of particular interest: Cellular and molecular neuroscience—Studies of the mechanisms of neuronal excitability and development, and of the genetic basis of behavior. Neural systems—Studies of the integrative function of the nervous system. Translational research—Studies designed to improve the prevention, diagnosis, treatment and our understanding of the causes of neurological and psychiatric disorders. The award of $225,000 is payable over a three-year period beginning July 1.  Applications, including three letters of recommendation, are due 11:59 pm EST on February 15, 2018.
American Brain Tumor Association –
·         Research Collaboration Grant Program ($200,000 award, deadline September 27th, 2017).  http://www.abta.org/brain-tumor-research/research-grants/  ARC Grants are two year, $200,000 grants intended to promote team science in a way that will streamline and accelerate progress and affect the desired change in clinical outcome for brain tumors. Research projects supported under this mechanism must be conducted by a team of at least two co-principal investigators (Co-PI's) from distinct institutions. The research project should be multi-disciplinary in that it incorporates multiple components such as basic, translational, clinical and epidemiological research. The ARC Grant Program requires a Letter of Intent (LOI).  The ABTA Grant Application Portal is accepting these LOIs from August 16, 2017 to September 27, 2017 at noon Central Time.
·         Basic Research Fellowship Program ($100,000 award, deadline September 27th, 2017).  http://www.abta.org/brain-tumor-research/research-grants/  Basic Research Fellowship Grants are two year, $100,000 grants supporting postdoctoral fellows conducting brain tumor research. Fellows must include a lead mentor who currently conducts brain tumor research at the same academic institution in an effort to provide research, scientific management and other leadership guidance necessary to foster the applicant’s career advancement. The ABTA Grant Application Portal is accepting Basic Research Fellowship LOIs from August 16, 2017 to September 27, 2017 at noon Central Time.
Orphan Disease Center – University of Pennsylvania 2017 Million Dollar Bike Ride Pilot Grant Program ($101,164 award, deadline September 18th, 2017). http://www.med.upenn.edu/orphandisease/rare-disease-overview.html  The 2017 Million Dollar Bike Ride Pilot Grant Program is now open!  The MDBR Pilot Grant Program provides a one-year grant to support research related to a rare disease represented in the 2017 Million Dollar Bike Ride.  Research Focus Areas for Pilot Grants: please see pages 8 – 11 of the attached Word report summary for a complete listing of the 22 orphan disease conditions eligible for research grant awards this year.
Promobilia Foundation – Grants for Research & Development Projects ($100,000 award, deadline October 12th, 2017).  http://www.promobilia.se/?lang=en  The aim of the Foundation is to promote the development of technical aids so that disabled persons could benefit of a more active life. Our task is to support research and development of technical aids as well as ensure they get into production and reach the needy. The Foundation mainly gives support for development of tools for mobility handicapped but has also supported research about the comprehension of reading and writing difficulties. The Foundation has also supported research around diseases that could lead to severe motion problems. Grants for research- and development projects: The Foundation Promobilia set aside funds to support research and development projects. The Foundation Promobilia supports research and development projects. We give grants in the range of SEK 100,000 – 500,000 (in USD about 10,000 – 100,000). Applications shall be posted to Promobilia not later than Thursday, October 12th, 2017.